XBiotech

XBITNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$57.012 M

$1.87 -4.10%

Close of 6 Nov 2026

As of 6 Nov 2026, XBiotech (XBIT) has a market capitalization of $57.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$45.5M

Loss-making

Shares outstanding

30,487,731

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#321Gossamer BioGOSS$57.9M
#322Telomir PharmaceuticalsTELO$57.5M
#323XBiotechXBIT$57.0M
#324Nomad Power SolutionsNMAD$56.4M
#325CleneCLNN$56.2M

What if XBiotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$926,171.71

Per share 495,279× higher

Bitcoin $1.53T

$50,113.54

Per share 26,799× higher

Apple $5.02T

$164,518.07

Per share 87,978× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for XBiotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.